Forensic Analysis · Trading Companies & Distributors · as of Jul 22, 2026
Wellgistics Health, Inc. (WGRX)
A forensic read on Wellgistics Health, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
F · Poor — capital at risk
Forensic grade
Distress
Financial health
-38.7
Altman Z-score
Clean
Earnings quality
4
Forensic signals
28.7%
Revenue growth
Financial health / Altman Z-score above is based on book value, not market value — this free snapshot doesn't pull live market data. Treat it as a rough read, not the final word.
Wellgistics Health, Inc. earns a F (Poor — capital at risk) forensic quality grade, and its Altman Z-score is -38.7, placing it in the Distress zone (based on book value, not market value, since this free snapshot doesn't pull live market data — treat this zone as a rough read, not the final word). 4 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-642.7%
FY2025
Return on invested capital.Return on invested capital is -642.7% in the latest fiscal year and slipping from -16% — well below its ~8% cost of capital, so reinvested dollars may be destroying value, not building it.
+50.2%/yr
FY2024–FY2025
Share-count dilution.Diluted share count changed +50% over the last 1 years to FY2025 (+50.2%/yr). The count is GROWING — existing holders are being diluted. That's ~50.2% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2024 has been diluted ~33%.
235% of rev
FY2025
Stock-based comp load.Stock-based compensation ran 235% of revenue in FY2025 — about $0.77 per diluted share. Meaningful — reported free cash flow flatters the economics, since SBC is a real cost paid in shares.
$13M
FY2025–FY2025
Goodwill impairments.Took $13M of goodwill writedowns across 1 year (FY2025 ($13M)). Writedowns mean past acquisitions underperformed what was paid for them — worth weighing on capital-allocation skill.
Key fundamentals
Latest Revenue$23.3M
Revenue Growth YoY+28.7%
Net Margin-433.9%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on Wellgistics Health, Inc.:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about WGRX's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown